01.20.2015
Improve Outcomes
$18.15
12 months
Self-Monitoring of C-Peptide to Frequently Test Beta-Cell Function in Type 1 Diabetes
Funding to validate an investigational technology that will allow frequent, simultaneous self-monitoring of blood glucose and C-peptide to assess beta-cell function in people with type 1 diabetes.